These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 5362847)

  • 1. Differential monoamine depletion by oxypertine in nerve terminals. Granulated synaptic vesicles in relation to depletion of norepinephrine, dopamine and serotonin.
    Bak IJ; Hassler R; Kim JS
    Z Zellforsch Mikrosk Anat; 1969; 101(3):448-62. PubMed ID: 5362847
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential depletion of storage sites for noradrenalin, dopamine and serotonin by oxypertin].
    Hassler R; Bak IJ; Kim JS
    Nervenarzt; 1970 Mar; 41(3):105-18. PubMed ID: 5447883
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
    Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
    Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
    [No Abstract]   [Full Text] [Related]  

  • 4. The noradrenaline content of the varicosities of sympathetic adrenergic nerve terminals in the rat.
    Dahlström A; Häggendal J; Hökfelt T
    Acta Physiol Scand; 1966; 67(3):289-94. PubMed ID: 6007784
    [No Abstract]   [Full Text] [Related]  

  • 5. Some observations on the site of action of oxypertin.
    Fuxe K; Grobecker H; Hökfelt T; Jonsson J; Malmfors T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(4):450-63. PubMed ID: 5622482
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiation of norepinephrine storage compartments in peripheral adrenergic nerves.
    Van Orden LS; Schaefer JM; Burke JP; Lodoen FV
    J Pharmacol Exp Ther; 1970 Sep; 174(3):357-68. PubMed ID: 5456169
    [No Abstract]   [Full Text] [Related]  

  • 7. Catecholamine and serotonin in granulated vesicles of nerve endings in the pineal gland of the rat.
    De Iraldi AP; Gueudet R
    Int J Neuropharmacol; 1969 Jan; 8(1):9-14. PubMed ID: 5783000
    [No Abstract]   [Full Text] [Related]  

  • 8. Lesions of central norepinephrine terminals with 6-OH-dopamine: biochemistry and fine structure.
    Bloom FE; Algeri S; Groppetti A; Revuelta A; Costa E
    Science; 1969 Dec; 166(3910):1284-6. PubMed ID: 5350323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemistry of the extrapyramidal system--from anatomical viewpoint].
    Sano Y; Murase Y
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):859-68. PubMed ID: 4898006
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. II. Accumulation of 5-hydroxytryptamine in nerve vesicles containing norepinephrine in rat vas deferens.
    Zieher LM; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):30-41. PubMed ID: 5087403
    [No Abstract]   [Full Text] [Related]  

  • 11. Degenerative and nondegenerative effects of 6-hydroxydopamine on adrenergic nerves.
    Jonsson G; Sachs C
    J Pharmacol Exp Ther; 1972 Mar; 180(3):625-35. PubMed ID: 4335111
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent developments on the ultrastructural aspect of adrenergic nerve endings in various experimental conditions.
    Tranzer JP; Thoenen H; Snipes RL; Richards JG
    Prog Brain Res; 1969; 31():33-46. PubMed ID: 4900115
    [No Abstract]   [Full Text] [Related]  

  • 13. An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content.
    Bloom FE; Aghajanian GK
    J Pharmacol Exp Ther; 1968 Feb; 159(2):261-73. PubMed ID: 5638647
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. 3. Selective increase of norepinephrine in the rat pineal gland consecutive to depletion of neuronal 5-hydroxytryptamine.
    Jaim-Etcheverry G; Zeiher LM
    J Pharmacol Exp Ther; 1971 Jul; 178(1):42-8. PubMed ID: 4253294
    [No Abstract]   [Full Text] [Related]  

  • 15. Degeneration of adrenergic nerves produced by 6-hydroxydopamine.
    Malmfors T; Sachs C
    Eur J Pharmacol; 1968 Apr; 3(1):89-92. PubMed ID: 5654676
    [No Abstract]   [Full Text] [Related]  

  • 16. 6-hydroxytryptamine--a new tool in monoamine fluorescence histochemistry.
    Jonsson G; Fuxe K; Hamberger B; Hökfelt T
    Brain Res; 1969 Mar; 13(1):190-5. PubMed ID: 5806139
    [No Abstract]   [Full Text] [Related]  

  • 17. Uptake and storage of catecholamines in rabbit brain after chronic reserpine treatment.
    Dahlström A; Fuxe K; Hamberger B; Hökfelt T
    J Pharm Pharmacol; 1967 Jun; 19(6):345-9. PubMed ID: 4382362
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of beta-phenylethylamine on central and peripheral monoamine-containing neurons.
    Fuxe K; Grobecker H; Jonsson J
    Eur J Pharmacol; 1967 Dec; 2(3):202-7. PubMed ID: 5590344
    [No Abstract]   [Full Text] [Related]  

  • 19. Fine structural identification of a reserpine-resistant norepinephrine store in adrenergic nerve terminals in guinea-pig atria.
    Van Orden LS; Schaefer JM; Antonaccio MJ; Smith CB
    J Pharmacol Exp Ther; 1974 Mar; 188(3):668-75. PubMed ID: 4131521
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of dopamine, noradrenaline and 5-hydroxytryptamine varicosities in a fraction containing nerve ending particles.
    Fuxe K; Grobecker H; Hökfelt T; Jonsson G
    Brain Res; 1967 Nov; 6(3):475-80. PubMed ID: 6076252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.